Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PE
576
DELISTED
PARSLEY ENERGY INC
PE
| $28.6K | 0.04% |
3,058,768
-1,445,110
| -32% | -$15.5M |
|
577
Alcon
ALC
$35B
| $28.6K | 0.04% |
501,819
+450,869
| +885% | +$26.5M |
|
578
Acuity Brands
AYI
$10.8B
| $28.6K | 0.04% |
279,192
-94,551
| -25% | -$9.71M |
|
579
Graco
GGG
$13.5B
| $28.6K | 0.04% |
465,380
+41,503
| +10% | +$2.32M |
|
580
AutoNation
AN
$6.92B
| $28.5K | 0.04% |
538,015
+35,448
| +7% | +$1.85M |
|
581
Mercado Libre
MELI
$92.3B
| $28.4K | 0.04% |
26,278
+3,157
| +14% | +$3.43M |
|
582
Kinder Morgan
KMI
$68.7B
| $28.4K | 0.04% |
2,305,476
-457,279
| -17% | -$6.37M |
|
583
CALL
Target
TGT
$68B
| $28.4K | 0.03% |
180,300
-12,800
| -7% | -$1.76M |
|
584
Curtiss-Wright
CW
$25.5B
| $28.2K | 0.03% |
302,290
-103,482
| -26% | -$9.93M |
|
585
Prosperity Bancshares
PB
$8.89B
| $28.1K | 0.03% |
542,077
+328,086
| +153% | +$18M |
|
586
FIVE9
FIVN
$2.54B
| $28K | 0.03% |
215,683
-319,530
| -60% | -$38.4M |
|
587
PUT
Union Pacific
UNP
$174B
| $27.9K | 0.03% |
141,800
-43,500
| -23% | -$8.08M |
|
|
AZEK
588
DELISTED
The AZEK Co
AZEK
| $27.8K | 0.03% |
799,410
+720,424
| +912% | +$25.1M |
|
|
NTCO
589
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $27.8K | 0.03% |
1,525,883
-105,013
| -6% | -$1.84M |
|
590
CALL
Booking.com
BKNG
$161B
| $27.7K | 0.03% |
405,000
+7,500
| +2% | +$527K |
|
|
BMY.RT
591
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $27.7K | 0.03% |
12,313,741
+694,687
| +6% | +$1.98M |
|
|
ALXN
592
DELISTED
Alexion Pharmaceuticals
ALXN
| $27.7K | 0.03% |
242,065
-136,878
| -36% | -$14.8M |
|
|
APLS
593
DELISTED
Apellis Pharmaceuticals
APLS
| $27.7K | 0.03% |
916,703
-158,547
| -15% | -$4.74M |
|
594
Western Union
WU
$2.21B
| $27.6K | 0.03% |
1,289,950
-147,250
| -10% | -$3.34M |
|
595
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
| $27.6K | 0.03% |
261,903
-240,964
| -48% | -$25.4M |
|
|
CMLFU
596
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $27.6K | 0.03% |
+2,632,318
| New | +$27.7M |
|
597
IDEX
IEX
$17.3B
| $27.6K | 0.03% |
151,066
+168
| +0.1% | +$29.1K |
|
598
SI-BONE Inc
SIBN
$834M
| $27.5K | 0.03% |
1,159,768
-29,716
| -2% | -$590K |
|
|
RETA
599
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $27.5K | 0.03% |
282,007
-36,170
| -11% | -$4.52M |
|
|
CNH
600
CNH Industrial
CNH
$17.5B
| $27.4K | 0.03% |
4,023,228
+3,402,700
| +548% | +$22.6M |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.